metformin has been researched along with Intestinal Diseases in 3 studies
Metformin: A biguanide hypoglycemic agent used in the treatment of non-insulin-dependent diabetes mellitus not responding to dietary modification. Metformin improves glycemic control by improving insulin sensitivity and decreasing intestinal absorption of glucose. (From Martindale, The Extra Pharmacopoeia, 30th ed, p289)
metformin : A member of the class of guanidines that is biguanide the carrying two methyl substituents at position 1.
Intestinal Diseases: Pathological processes in any segment of the INTESTINE from DUODENUM to RECTUM.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 3 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Xiao, Y | 1 |
| Li, K | 1 |
| Bian, J | 1 |
| Liu, H | 1 |
| Zhai, X | 1 |
| El-Omar, E | 1 |
| Han, L | 1 |
| Gong, L | 1 |
| Wang, M | 1 |
| Jang, H | 3 |
| Kim, S | 3 |
| Kim, H | 3 |
| Oh, SH | 3 |
| Kwak, SY | 1 |
| Joo, HW | 1 |
| Lee, SB | 3 |
| Jang, WI | 3 |
| Park, S | 3 |
| Shim, S | 3 |
| Kim, JM | 2 |
| Park, M | 2 |
3 other studies available for metformin and Intestinal Diseases
| Article | Year |
|---|---|
Urolithin A Attenuates Diabetes-Associated Cognitive Impairment by Ameliorating Intestinal Barrier Dysfunction via N-glycan Biosynthesis Pathway.
Topics: Animals; Cognitive Dysfunction; Coumarins; Diabetes Mellitus, Type 2; Diet, High-Fat; Inflammation; | 2022 |
Metformin Protects the Intestinal Barrier by Activating Goblet Cell Maturation and Epithelial Proliferation in Radiation-Induced Enteropathy.
Topics: Animals; beta Catenin; Cell Proliferation; Goblet Cells; Intestinal Diseases; Intestinal Mucosa; Int | 2022 |
Combined Administration of Pravastatin and Metformin Attenuates Acute Radiation-Induced Intestinal Injury in Mouse and Minipig Models.
Topics: Animals; Diabetes Mellitus, Type 2; Intestinal Diseases; Intestines; Metformin; Mice; Pravastatin; R | 2022 |
Combined Administration of Pravastatin and Metformin Attenuates Acute Radiation-Induced Intestinal Injury in Mouse and Minipig Models.
Topics: Animals; Diabetes Mellitus, Type 2; Intestinal Diseases; Intestines; Metformin; Mice; Pravastatin; R | 2022 |
Combined Administration of Pravastatin and Metformin Attenuates Acute Radiation-Induced Intestinal Injury in Mouse and Minipig Models.
Topics: Animals; Diabetes Mellitus, Type 2; Intestinal Diseases; Intestines; Metformin; Mice; Pravastatin; R | 2022 |
Combined Administration of Pravastatin and Metformin Attenuates Acute Radiation-Induced Intestinal Injury in Mouse and Minipig Models.
Topics: Animals; Diabetes Mellitus, Type 2; Intestinal Diseases; Intestines; Metformin; Mice; Pravastatin; R | 2022 |